内窥镜下玻切治疗严重眼外伤后的无光感

注册号:

Registration number:

ChiCTR2200055985 

最近更新日期:

Date of Last Refreshed on:

2024-07-21 23:34:46 

注册时间:

Date of Registration:

2022-01-30 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

内窥镜下玻切治疗严重眼外伤后的无光感

Public title:

Endoscopic vitrectomy in the treatment of severly traumatic eyes without light perception

注册题目简写:

English Acronym:

研究课题的正式科学名称:

内窥镜下玻切治疗严重眼外伤后的无光感

Scientific title:

Endoscopic vitrectomy in the treatment of severly traumatic eyes without light perception

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

杨勋 

研究负责人:

杨勋 

Applicant:

Xun Yang 

Study leader:

Xun Yang 

申请注册联系人电话:

Applicant telephone:

+86 139 8212 8299

研究负责人电话:

Study leader's
telephone:

+86 139 8212 8299

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

dryangxun@163.com

研究负责人电子邮件:

Study leader's E-mail:

dryangxun@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江苏省苏州市姑苏区干将东路200号

研究负责人通讯地址:

江苏省苏州市姑苏区干将东路200号

Applicant address:

200 Gangjiang Road East, Gusu Distict, Suzhou, Jiangsu, China

Study leader's address:

200 Gangjiang Road East, Gusu Distict, Suzhou, Jiangsu, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

苏州理想眼科医院

Applicant's institution:

Suzhou Lixiang Eye hospital

研究负责人所在单位:

苏州理想眼科医院

Affiliation of the Leader:

Suzhou Lixiang Eye hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

SLER2020127

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

苏州理想眼科医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Suzhou Lixiang Eye Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2020-10-01 00:00:00

伦理委员会联系人:

杨勋

Contact Name of the ethic committee:

Xun Yang

伦理委员会联系地址:

江苏省苏州市姑苏区干将东路200号

Contact Address of the ethic committee:

200 Gangjiang Road East, Gusu Distict, Suzhou, Jiangsu, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

苏州理想眼科医院

Primary sponsor:

Suzhou Lixiang Eye hospital

研究实施负责(组长)单位地址:

江苏省苏州市姑苏区干将东路200号

Primary sponsor's address:

200 Gangjiang Road East, Gusu Distict, Suzhou, Jiangsu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

苏州

市(区县):

Country:

China

Province:

Suzhou

City:

单位(医院):

苏州理想眼科医院

具体地址:

江苏省苏州市姑苏区干将东路200号

Institution
hospital:

Suzhou Lixiang Eye hospital

Address:

200 Gangjiang Road East, Gusu Distict, Suzhou, Jiangsu, China

经费或物资来源:

苏州理想眼科医院

Source(s) of funding:

Suzhou Lixiang Eye hospital

研究疾病:

严重眼外伤后的无光感  

Target disease:

severely traumatic eyes without light perception

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

单臂 

Study design:

Single arm 

研究目的:

研究内窥镜下玻切对无光感病人的治疗效果。  

Objectives of Study:

To study the therapeutic effect of endoscopicvitrectomy for patients without light perception

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

不愿意内窥镜手术。

Exclusion criteria:

Unwilling to undergo endoscopic surgery

研究实施时间:

Study execute time:

From 2022-03-05 00:00:00 To 2024-10-05 00:00:00  

征募观察对象时间:

Recruiting time:

From 2003-01-01 00:00:00 To 2019-10-05 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

104

Group:

intervention group

Sample size:

干预措施:

手术治疗

干预措施代码:

Intervention:

surgical therapy

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏 

市(区县):

苏州 

Country:

China

Province:

Jiangsu

City:

Suzhou

单位(医院):

苏州理想眼科医院 

单位级别:

三级 

Institution
hospital:

Suzhou Lixiang Eye Hospital

Level of the institution:

tertiary hospital

测量指标:

Outcomes:

指标中文名:

眼压、视力

指标类型:

主要指标

Outcome:

intraocular pressure and visual acuity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 5 years
最大 Max age 78 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

none

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

electronic data capture

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-01-30 06:23:11